Researchers analyzed data from the Cooperative Cardiovascular Project, a study of Medicare beneficiaries hospitalized for acute myocardial infarction that includes 17 years of follow-up data. The researchers compared the life expectancy rates in patients admitted to hospitals with low and high 30-day risk-standardized mortality rates.
Using a sample of more than 119,000 patients across more than 1,800 hospitals, the researchers found patients admitted to hospitals with the lowest 30-day risk-standardized mortality rate lived an average of 6.44 years after their heart attack. Those admitted to hospitals with the highest 30-day risk-standardized mortality rates lived for an average of 5.54 years after their heart attack.
All total, for every 1,000 patients treated in a lower-performing hospital, 1,124 years of life were lost compared to patients treated in higher-performing hospitals, a meaningful loss in life expectancy for patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
